https://www.has-sante.fr/jcms/p_3576072/fr/padcev-enfortumab-vedotin-carcinome-urothelial 2025 false false false France Urothelial Carcinoma Urothelial Carcinoma evaluation of the transparency committee evaluation of the transparency committee enfortumab vedotin enfortumab vedotin carcinoma carcinoma enfortumab vedotin enfortumab vedotin
--- https://www.has-sante.fr/jcms/p_3477569/fr/padcev-enfortumab-vedotin-carcinome-urothelial 2023 France evaluation of the transparency committee enfortumab vedotin enfortumab vedotin carcinoma Urothelial Carcinoma Enfortumab Vedotin
--- https://www.has-sante.fr/jcms/p_3395521/fr/padcev-enfortumab-vedotin-carcinome-urothelial 2022 France evaluation of the transparency committee evaluation of the transparency committee enfortumab vedotin enfortumab vedotin enfortumab vedotin enfortumab vedotin
Currated CISMeF NLP mapping